Estramustine is a class of cytotoxic chemotherapy drugs used in the treatment of certain forms of prostate cancer. The drug works on the principle of increasing estrogen interferes with prostate cancer and slows and stops the growth of cancer cells.

Enasidenib is indicated for the treatment of adult patients with recurrent or refractory acute myeloid leukemia (AML) with isocitrate dehydrogenase-2 (IDH2) mutations. Follow the article to better understand the use of Enasidenib.